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Abstract. 
 
As for most integral membrane proteins, the 
intracellular transport of retroviral envelope glycopro-
teins depends on proper folding and oligomeric assem-
bly in the ER. In this study, we considered the hypothe-
sis that a panel of 22 transport-defective mutants of the 
human T cell leukemia virus type 1 envelope glycopro-
tein might be defective in ER assembly. Upon cell 
cotransfection with wild-type envelope, however, the 
vast majority of these transport-defective mutants (21 
of 22) exerted a speciﬁc trans-dominant negative effect. 
This effect was due to random dimerization of the mu-
tated and wild-type glycoproteins that prevented the in-
tracellular transport of the latter. This unexpected re-
sult suggests that association of glycoprotein monomers 
precedes the completion of folding. The only mutation 
that impaired this early assembly was located at the 
NH
 
2
 
 terminus of the protein. COOH-terminally trun-
cated, soluble forms of the glycoprotein were also 
trans-dominant negative provided that their NH
 
2
 
 termi-
nus was intact. The leucine zipper-like domain, al-
though involved in oligomerization of the envelope gly-
coproteins at the cell surface, did not contribute to their 
intracellular assembly. We propose that, at a step subse-
quent to translation, but preceding complete folding
of the monomers, glycoproteins assemble via their 
NH
 
2
 
-terminal domains, which, in turn, permits their co-
operative folding.
Key words: protein processing • posttranslational • 
viral envelope proteins • genes, dominant • human T 
cell leukemia virus
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 surface proteins are usually oligomers, and
reach the plasma membrane after they undergo
stepwise processes which ensure their structural
integrity (Hurtley and Helenius, 1989; Einfeld and Hunter,
1991). Viral envelope glycoproteins have been extensively
used as models for defining the main characteristics of the
cellular “quality control” of membrane proteins because,
although encoded by viruses, they follow the normal secre-
tory pathway also used by the cellular proteins of the
plasma membrane (Doms et al., 1993). Studies of the influ-
enza hemagglutinin (HA)
 
1
 
 precursor HA0 and of the ve-
sicular stomatitis virus (VSV) G protein showed that, as a
rule, quality control over newly synthesized membrane
proteins is exerted primarily by the ER: only membrane
glycoproteins that are correctly folded and oligomerized
can leave the ER and proceed to the Golgi complex and
beyond, whereas proteins with incorrect tertiary or quater-
nary structure are retained in the ER and eventually de-
graded. Excess misfolded protein can, however, escape
this ER control, in which case the intermediate compart-
ment and the cis-Golgi intervene as a back-up quality con-
trol system to recycle the protein back to the ER via retro-
grade transport (Hammond and Helenius, 1994).
Folding of membrane proteins begins during their co-
translational translocation in the ER compartment, and
continues posttranslationally. The rate and efficiency of
folding vary considerably among proteins. Important dif-
ferences reside in the time required and the nature of the
intermediates formed before the acquisition of the mature
oligomeric conformation. For VSV G, but not for HA0,
the normal folding process involves the transient forma-
tion of multimolecular complexes (de Silva et al., 1993). In
both cases, the bona fide trimeric assembly is a posttrans-
lational and kinetically late step in the sequence of events
leading to the transport-competent conformation. Indeed,
it occurs after the monomers have reached their fully oxi-
dized form and characteristic immunoreactivity (Copeland
et al., 1988; de Silva et al., 1993; Tatu et al., 1993, 1995).
This supports the contention that extensive folding must
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Abbreviations used in this paper: 
 
CMV, cytomegalovirus; HA, influenza
virus hemagglutinin; HTLV, human T cell leukemia virus; SU, surface gly-
coprotein; TM, transmembrane glycoprotein; VSV, vesicular stomatitis vi-
rus; wt, wild-type. 
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take place for monomeric subunits to recognize each other
as specific assembly partners (Doms et al., 1993). In the
case of the hemagglutinin-neuraminidase glycoprotein of
the human parainfluenza virus type 3, however, oligomeric
assembly occurs as an early event that precedes the acqui-
sition of correct intramolecular disulfide bonds and ma-
ture immunoreactivity (Collins and Mottet, 1991).
Retroviral envelope glycoproteins also constitute a good
model for studying the maturation steps required for pro-
tein transport out of the ER (Einfeld, 1996). These enve-
lope proteins are first synthesized in the ER as a precursor
membrane protein, which is then transported to the Golgi
apparatus where its cleavage into two mature products oc-
curs, mediated by a furin-like cellular protease. Transport
competence is thus easily monitored by the appearance of
the cleaved viral products, the surface (SU) and the trans-
membrane (TM) glycoproteins. Among retroviral enve-
lopes, that of the human T cell leukemia virus type 1
(HTLV-1), an oncogenic human retrovirus, provides an
interesting model for exploring the limiting steps for the
acquisition of transport competence, because the quality
control exerted over the structural integrity of the precur-
sor glycoprotein is remarkably stringent (Pique et al.,
1990; Delamarre et al., 1996). Indeed, most of the muta-
tions that we have artificially introduced in the HTLV-1
glycoprotein result in a lack of precursor cleavage, which
most probably indicates retention of the precursor in the
ER. In the present study, we took advantage of our large
series of mutants to examine whether the defect in in-
tracellular transport exhibited by these glycoproteins
might  actually reflect a defect in oligomeric assembly. We
designed a dominant negative assay (Herskowitz, 1987)
in which the retained glycoproteins were systematically
tested for their ability to interfere in trans with the trans-
port and hence function of the wild-type (wt) glycoprotein.
We found, unexpectedly, that the vast majority of the mu-
tated glycoproteins that could not be transported into the
Golgi apparatus and beyond were nevertheless capable of
specific dimeric association with the wt precursor glyco-
protein. That incompetence for assembly was rarely re-
sponsible for the intracellular retention of these glycopro-
teins suggests the occurrence of an early assembly step
preceding the completion of folding.
 
Materials and Methods
 
Plasmids
 
The HTLV envelope expression vectors used in this study are the previ-
ously described plasmids CMV-ENV-1 (Delamarre et al., 1997) and
CMV-ENV-2 (Rosenberg et al., 1998), which contain the respective
HTLV-1 and HTLV-2 sequences corresponding to the 
 
env
 
, 
 
tax
 
, and 
 
rex
 
genes, under the control of the simian cytomegalovirus (CMV) promoter.
The CMV-ENV
 
D
 
PvuII and CMV-ENV
 
D
 
PmaCI constructs were used as
the respective negative controls (Delamarre et al., 1997; Rosenberg et al.,
1998). The mutated constructs coding for HTLV-1 glycoproteins with sin-
gle amino acid substitutions were described elsewhere (Delamarre et al.,
1997; Rosenberg et al., 1997). The CMV-ENV438-stop plasmid encodes a
soluble form of the HTLV-1 glycoprotein under the control of the CMV
promoter (Pique et al., 1993; Rosenberg et al., 1997)
 
.
 
 The human immuno-
deficiency virus type 1 (HIV-1) envelope expression plasmid pMA243,
which is derived from an HIV-1
 
LAI
 
 provirus and has the capacity for en-
coding the viral proteins Env, Tat, Rev, and Vpu, was a gift from M. Ali-
zon (INSERM U332, ICGM, Paris, France) (Dragic et al., 1992).
 
Mutagenesis and Cloning 
 
Oligonucleotide-directed mutagenesis of the sequence encoding the SU
portion of the HTLV-2 envelope protein was performed as described else-
where (Rosenberg et al., 1998). The constructs coding for HTLV-1 enve-
lope proteins with truncations or deletions were generated using standard
cloning techniques. Positions in the amino acid sequence of the HTLV-1
envelope protein are numbered from the initiator methionine. The loca-
tions of truncations and deletions relative to other features of the HTLV-1
envelope protein are depicted in Fig. 6.
 
Cell Lines 
 
COS-1 and HeLa cells were obtained from the American Type Culture
Collection. CosLTRLacZ cells, which are COS cells stably expressing the
bacterial 
 
b
 
-galactosidase gene (
 
lacZ
 
) under the control of the HIV-1 long
terminal repeat (LTR), and HeLa-Tat cells, which are HeLa cells stably
expressing the HIV-1 
 
tat
 
 gene, were a gift from M. Alizon (Dragic et al.,
1992). Also provided by M. Alizon were the HeLa-P4 cells, which are
HeLa cells stably expressing both the 
 
lacZ
 
 gene under the control of the
HIV-1 LTR and the human CD4 cDNA (Clavel and Charneau, 1994). All
cell lines were grown in DME containing 50 
 
m
 
g/ml gentamicin and 5%
FCS, and supplemented with 300 
 
m
 
g/ml hygromycin B (Calbiochem
Corp.) for the CosLTRLacZ cells, or with 500 
 
m
 
g/ml G-418 sulphate (Ge-
neticin, Life Technologies, Inc.) for the HeLa-P4 cells. Cell cultures were
maintained at 37
 
8
 
C in a humidified 5% CO
 
2
 
 atmosphere.
 
Syncytium Formation Assays
 
The quantitative assays used to evaluate syncytium formation elicited by
the HTLV-1, HTLV-2, or HIV-1 envelopes have been described else-
where (Dragic et al., 1992; Delamarre et al., 1997; Rosenberg et al., 1998).
In all these assays, the HIV-1 LTR-driven expression of 
 
b
 
-galactosidase is
transactivated by the Tat protein upon fusion of envelope-expressing cells
with receptor-bearing indicator cells. To assess the dominant negative ef-
fect of the glycoprotein mutants on syncytium formation induced by the
wt HTLV-1 or HTLV-2 glycoproteins, the mutated and wt envelope con-
structs (total amount: 3 
 
m
 
g DNA) were cotransfected into CosLTRLacZ
cells seeded at 3 
 
3 
 
10
 
5
 
 cells per 60-mm–diameter dish the previous day by
a procedure using DEAE-dextran, chloroquine, and dimethyl sulfoxide
(Cullen, 1987). Immunofluorescence analysis of the cells cotransfected
with the constructs for the wt HTLV-1 envelope and for a truncation mu-
tant demonstrated that more than 95% of the cells that expressed one of
the envelope constructs in fact expressed both of them (data not shown).
Radioimmunoprecipitation analysis also assured us that, within the range
of DNA quantities used in this study, the level of protein expressed corre-
lated with the amount of DNA transfected. 1 d (HTLV-2) or 2 d (HTLV-1)
after transfection, 5 
 
3 
 
10
 
5
 
 HeLa-Tat cells were added as indicator cells.
After a 24-h coculture, the amount of 
 
b
 
-galactosidase was evaluated by a
chemiluminescence assay for detection of the activity of this enzyme in
cell lysates (Galacto-Light; Tropix) with a luminometer (Lumat LB 9501;
Berthold) (Delamarre et al., 1997; Rosenberg et al., 1998). To assess the
effect of the HTLV-1 glycoprotein mutants on syncytium formation in-
duced by the wt HIV-1 envelope, the mutated HTLV-1 envelope con-
structs (2.25 
 
m
 
g) and the pMA243 plasmid (5 ng) were cotransfected into
COS-1 cells seeded at 3 
 
3
 
 10
 
5
 
 cells per 60-mm–diameter dish the previous
day (Cullen, 1987). 2 d after transfection, 5 
 
3
 
 10
 
5
 
 HeLa-P4 cells were
added as indicator cells. After a 24-h coculture, syncytia were stained in
situ and counted under a light microscope as described elsewhere (Dragic
et al., 1992). For each assay, the syncytium formation index gives the per-
centage fusion induced by the wt envelope in the presence of the glyco-
protein mutant relative to that obtained in its absence.
 
Immunofluorescence Microscopy
 
The envelope constructs were transfected into COS-1 or HeLa cells by the
calcium phosphate precipitation method. 1 d after transfection, the cells
were seeded onto glass slides (Lab-Tek; Nunc, Inc.) at 4 
 
3
 
 10
 
4
 
 cells per
80-mm
 
2
 
 well. The next day, cultures were rinsed in PBS and fixed with 4%
paraformaldehyde for 15 min at room temperature, followed by quench-
ing in 0.1 M glycine in PBS. Permeabilization and saturation were
achieved by a 2-h incubation in PBS containing 0.05% saponin and 0.2%
BSA, and all subsequent steps were performed in this buffer at room tem-
perature. The cells were incubated for 90 min with the primary antibodies.
These were mAb 1C11 (1:100; Epitope), which is a murine mAb directed
to the HTLV-1 SU (Palker et al., 1989), and rabbit polyclonal antibodies 
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directed to the 
 
a
 
 subunit of translocating chain-associating membrane
protein (1:500, kindly provided by T.A. Rapoport, Department of Cell Bi-
ology, Harvard Medical School, Boston, MA) or to Rab1 (1:25, kindly
provided by B. Goud, CNRS UMR 144, Institut Curie, Paris, France). Ex-
cess antibody was removed with five washes, and the secondary antibodies
were allowed to bind for 60 min. These were FITC-conjugated goat anti–
mouse IgG (1:400; Jackson ImmunoResearch Laboratories, Inc.) and cya-
nin 3–conjugated goat anti–rabbit IgG (1:300; Jackson ImmunoResearch
Laboratories, Inc.). After five washes, the slides were mounted in Mowiol
and observed with a confocal laser scanning microscope (MRC-1000; Bio-
Rad Laboratories, with a 60
 
3
 
 objective; Nikon Inc.). The pinhole aper-
ture was such that optical section thickness was 0.6 
 
m
 
m. “Bleed-through”
from the FITC to the cyanin channel was negligible. Images were pro-
cessed using the Laser Sharp software. Colocalization appeared as yellow
pixels after merging sections recorded at the same z level in each channel.
 
Radioimmunoprecipitation Assays
 
Immunoprecipitations of the HTLV-1 envelope glycoproteins were per-
formed as described in our previous studies (Pique et al., 1990), using pro-
tein A–Sepharose CL-4B beads (Pharmacia Biotechnology) coated with a
pool of sera from HTLV-1–infected individuals (provided by J. Coste,
CRTS, Montpellier, France). For coimmunoprecipitation experiments,
protein A–Sepharose beads were coated with rabbit anti–mouse Ig (Dako
SA) plus purified 4D4 mAb, which is a murine mAb raised against a syn-
thetic peptide covering the COOH-terminal domain (amino acids 287–
311) of the HTLV-1 SU (kindly donated by C. Desgranges and M.-P.
Grange, INSERM U271, Lyon, France) (Grange et al., 1998). Immuno-
precipitates were electrophoresed in SDS-13% polyacrylamide gels under
reducing conditions (except where otherwise stated), and visualized by au-
toradiography.
 
Velocity Gradient Sedimentation
 
The envelope constructs were transfected into COS-1 cells (2.8 
 
3
 
 10
 
6
 
) by
the calcium phosphate precipitation method. 2 d after transfection, the
cells were lysed in 0.8 ml of 100 mM Tris-HCl, pH 8.0, containing 100 mM
NaCl, 1 mM CaCl
 
2
 
, and 250 mM 
 
n
 
-octyl-
 
b
 
-
 
D
 
-glucopyranoside (Sigma
Chemical Co.). The clarified lysates, together with 50 
 
m
 
l of size markers
(kD): 66 BSA, 141 alcohol dehydrogenase, and 250 catalase, each at 9 mg/ml
(Sigma Chemical Co.), were loaded onto continuous sucrose gradients (10 ml,
5–35% sucrose in 100 mM Tris-HCl, pH 8.0, containing 100 mM NaCl, 1 mM
CaCl
 
2
 
, and 40 mM 
 
n
 
-octyl-
 
b
 
-
 
D
 
-glucopyranoside) and centrifuged for 20 h
at 4
 
8
 
C in an SW41 rotor at 38,000 rpm before fractionation from the bot-
tom of the tube into 18 fractions of 600 
 
m
 
l. To analyze size markers, 60-
 
m
 
l
aliquots were removed from the fractions and were separated by SDS-
PAGE, followed by Coomassie blue staining. The remainders of the frac-
tions were subjected to immunoprecipitation with a pool of sera from
HTLV-1–infected individuals as described above. Immunoprecipitates
were electrophoresed in SDS-10% polyacrylamide gels under reducing
conditions, and proteins were transferred onto membranes (Immobilon-P;
Millipore Corp.). After saturation in PBS containing 0.05% Tween-20 and
5% skim milk, the membranes were incubated with a 1:3,000 dilution of
the mAb 4D4 (Grange et al., 1998) for 90 min at room temperature. Ex-
cess antibody was removed with six washes, and a 1:1,000 dilution of the
second-step antibody (peroxidase-conjugated goat anti–mouse IgG; Jack-
son ImmunoResearch Laboratories, Inc.) was allowed to bind for 60 min.
After eight washes, immunoreactive spots were detected by enhanced
chemiluminescence (Amersham Buchler GmbH).
 
Results
 
Negative Dominance as a Tool to Study Determinants 
of Envelope Precursor Assembly
 
We have previously described a series of HTLV-1 enve-
lope glycoprotein mutants that are defective in cleavage
of the precursor into the mature SU and TM products
(Delamarre et al., 1997; Rosenberg et al., 1997). The cleav-
age of the HTLV-1 glycoprotein precursor, which is re-
quired for envelope-mediated function, normally takes
place in the Golgi apparatus (Pique et al., 1992). As for
most integral membrane glycoproteins, transport into the
Golgi apparatus is thought to be strictly dependent on
proper folding and oligomeric assembly in the ER (Doms
et al., 1993). We thus considered the hypothesis that our
HTLV-1 glycoprotein mutants with defects in precursor
cleavage might actually be defective in precursor assem-
bly. We designed a dominant negative assay (Herskowitz,
1987) in which these cleavage-defective mutants were co-
expressed with the wt HTLV-1 glycoprotein in transfected
COS cells. In this approach, an assembly-competent mu-
tant would be expected to dominantly interfere with wt
envelope-mediated function by titrating the wt precursor
in the formation of transport-defective heterocomplexes;
in contrast, an assembly-defective mutant would spare the
intracellular maturation of the wt glycoprotein and hence
its function. Transfected cells expressing the wt HTLV-1
envelope at the cell surface are able to induce fusion with
indicator cells expressing the receptor, leading to the for-
mation of syncytia. Syncytium formation was thus chosen
as a convenient assay to account for intracellular transport
and hence function of the HTLV-1 envelope.
 
21 of 22 Cleavage-defective Glycoprotein Mutants Are 
Trans Dominant
 
Because several reports have suggested that the oligomer-
ization domain of retroviral envelopes lies in the TM gly-
coprotein (Einfeld and Hunter, 1988, 1994; Earl et al.,
1990; Rey et al., 1990; Thomas et al., 1991), we first investi-
gated the abilities of HTLV-1 glycoproteins with muta-
tions in the TM portion to interfere with wt envelope-
mediated function. We have previously described eight
single amino acid substitutions in the HTLV-1 TM that re-
sult in a lack of precursor cleavage and, consequently, in a
complete loss of syncytium-forming ability (Rosenberg et
al., 1997) (see Table I). The mutated envelope expression
plasmids were cotransfected with the wt envelope expres-
sion plasmid (CMV-ENV-1) at a ratio of 3:1, and syncy-
tium formation was monitored. Each of the eight cleavage-
defective TM mutants exerted a marked dominant negative
effect over the wt envelope, manifested by inhibition of
syncytium formation (Table I).
That all of the glycoproteins mutated in the TM portion
were able to interfere in trans with wt envelope-mediated
function prompted us to test for negative dominance of
glycoproteins mutated in the SU portion. We have previ-
ously described 14 single amino acid substitutions distrib-
uted throughout the HTLV-1 SU that abolish precursor
cleavage and hence envelope-mediated function (Delamarre
et al., 1997) (see Table II). A marked dominant negative
effect on the syncytium-forming activity of wt envelope
was documented for 13 of these 14 SU mutants (Table II).
Thus, the vast majority of HTLV-1 envelope mutants with
defects in cleavage of the precursor glycoprotein are trans-
dominant negative.
 
Specificity of the Trans-dominant Negative Effect
 
We examined whether the inhibitory effect exerted by the
mutants was specific for the HTLV-1 envelope. For this
purpose, we cotransfected each HTLV-1 glycoprotein mu-
tant construct with an expression vector encoding the wt
envelope glycoprotein of HIV-1 (pMA243), and we scored
the number of syncytia elicited by the HIV-1 envelope. In 
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contrast to their drastic effect on syncytium formation in-
duced by the wt HTLV-1 envelope, the HTLV-1 glycopro-
tein mutants failed to interfere with syncytium formation
induced by the wt HIV-1 envelope, even upon cotransfec-
tion of a 450-fold excess of the HTLV-1 plasmid (Tables I
and II). As a positive control, coexpression of CD4 with
the HIV-1 glycoprotein gave the expected inhibition of
syncytium formation (Bour et al., 1991; data not shown).
The dominant negative effect was thus specific, and could
not be accounted for by some general alteration of the in-
tracellular maturation or transport of membrane proteins.
 
Random Dimerization of wt and Mutated Glycoproteins
 
It has been shown that aggregation occurs in the ER of
cells synthesizing misfolded proteins (Hurtley et al., 1989)
and is not restricted to products from a single polysome
(Marquardt and Helenius, 1992). It could thus be argued
that the mutated glycoproteins might titrate the wt glyco-
protein in the formation of large heteroaggregates rather
than in a bona fide dimeric assembly process. To decide
between these two hypotheses, we combined different ap-
proaches.
We first examined the oligomeric structure of the enve-
lope glycoproteins from transfected cell lysates by velocity
sedimentation on sucrose gradients. Consistent with previ-
ous data (Paine et al., 1994), most of the wt HTLV-1 enve-
lope precursor glycoprotein was recovered in a peak at the
position expected for the dimeric form of this 61-kD pro-
tein (Fig. 1). A small amount of faster-sedimenting mate-
rial was also detected that might correspond to tetramer
formation. A similar pattern of sedimentation was de-
tected in lysates from cells coexpressing the wt glycopro-
tein plus a threefold excess of a cleavage-defective domi-
nant negative mutant (see the examples of the TM mutant
Arg379-Gly and of the SU mutant Asp171-Tyr in Fig. 1).
Notably, the position of the envelope glycoproteins did
not shift towards the bottom of the gradient, as would
have been expected if aggregation had occurred. We also
used nonreducing SDS-PAGE to analyze the envelope
products radioimmunoprecipitated from lysates of cotrans-
fected cells, because interchain disulfide-bonded com-
plexes often arise in the ER of cells synthesizing misfolded
proteins. No such complexes were detected (data not
shown), further arguing against an aggregation bias.
In addition to these biochemical approaches, we ex-
amined the extent of the trans-dominant negative inter-
ference exerted by the cleavage-defective mutants as a
function of the mutant:wt ratio (Fig. 2). In a cell that coex-
presses the wt glycoprotein and an assembly-competent
mutant, three dimer combinations are expected: homo-
dimers of wt precursor subunits, homodimers of mutant
precursor subunits, and heterodimers consisting of both
subunit types. If dimerization is random, the distribution
between these three combinations can be calculated for a
variety of expression ratios (Fig. 2 a). Cells were trans-
fected with a constant amount of DNA containing various
ratios of mutant to wt HTLV-1 envelope constructs (3:1,
1:1, and 1:3), and the resulting syncytium-forming activity
was compared with that observed after transfection of the
wt construct alone. As shown in Fig. 2 b for two TM and
two SU mutants, the experimental indices of syncytium
formation at each ratio approached the theoretical values
for the corresponding proportions of wt homodimers ex-
pected from a random dimerization process. This corrobo-
rates our biochemical findings, since trapping of wt glyco-
protein in a higher-order structure would have shifted the
experimental curves to the right. Therefore, the trans-
dominant negative effect most likely reflects random
 
Table I. Effect of Cleavage-defective HTLV-1 TM Mutants on 
Syncytium Formation Induced by wt Envelope
 
HTLV-1
glycoprotein
mutant
Precursor
cleavage
index (%)
Syncytium formation index (%)
Mutant*
Mutant 
 
1
 
wt HTLV-1 Env
 
‡
 
Mutant 
 
1
 
wt HIV-1 Env
 
§
 
Mutant*
 
Mock
 
i
 
,
 
20
 
,
 
5 100 100
Asp351-His
 
,
 
20
 
,
 
57 9 1
Leu368-Arg 29
 
,
 
5
 
,
 
5 113
Ala375-Asp 25
 
,
 
5 5 104
Arg379-Gly
 
,
 
20
 
,
 
51 2 8 6
Asp383-Tyr 20
 
,
 
59 8 8
Glu398-Val 32
 
,
 
51 0 9 6
Ser408-Phe 30 7 15 100
Leu419-Arg 31
 
,
 
51 3 8 5
 
*The precursor cleavage and syncytium formation indices for the HTLV-1 glycopro-
tein mutants relative to the wt HTLV-1 envelope glycoprotein are from our previous
studies (Rosenberg et al., 1997).
 
‡
 
Cells were cotransfected with the mutant constructs (2.25 
 
m
 
g) and the wt HTLV-1
envelope construct CMV-ENV-1 (0.75 
 
m
 
g). Data represent the means of at least three
independent transfections (standard errors were 
 
,
 
5%).
 
§
 
Cells were cotransfected with the mutant constructs (2.25 
 
m
 
g) and the wt HIV-1 en-
velope construct pMA243 (5 ng).
 
i
 
Cells were transfected with the negative control plasmid CMV-ENV
 
D
 
PvuII.
 
Table II. Effect of Cleavage-defective HTLV-1 SU Mutants on 
Syncytium Formation Induced by wt Envelope
 
HTLV-1
glycoprotein
mutant
Precursor
cleavage
index (%)
Syncytium formation index (%)
Mutant*
Mutant 
 
1
 
wt HTLV-1 Env
 
‡
 
Mutant 
 
1
 
wt HIV-1 Env
 
§
 
Mutant*
 
Mock
 
i
 
,
 
20
 
,
 
5 100 100
Ser25-Arg 22 6 72 91
Leu52-Arg
 
,
 
20
 
,
 
57 8 6
Asp53-Val
 
,
 
20
 
,
 
5 5 101
Ser58-Leu
 
,
 
20
 
,
 
58 9 8
Ser119-Leu
 
,
 
20
 
,
 
5
 
,
 
58 8
Tyr124-Asp
 
,
 
20
 
,
 
59 8 5
Ser130-Ile
 
,
 
20
 
,
 
5
 
,
 
5 100
Ser162-Phe
 
,
 
20
 
,
 
57 9 6
Asp171-Tyr
 
,
 
20
 
,
 
55 9 6
Ile173-Ser
 
,
 
20
 
,
 
5 10 100
Thr178-Ala
 
,
 
20
 
,
 
5
 
,
 
58 9
His238-Leu 21
 
,
 
5 15 112
Ser292-Tyr
 
,
 
20
 
,
 
51 3 8 7
Leu295-Arg 20
 
,
 
51 3 9 2
 
*The precursor cleavage and syncytium formation indices for the HTLV-1 glycopro-
tein mutants relative to the wt HTLV-1 envelope glycoprotein are from our previous
studies (Delamarre et al., 1997).
 
‡
 
Cells were cotransfected with the mutant constructs (2.25 
 
m
 
g) and the wt HTLV-1
envelope construct CMV-ENV-1 (0.75 
 
m
 
g). Data represent the means of at least three
independent transfections (standard errors were 
 
,
 
5%).
 
§
 
Cells were cotransfected with the mutant constructs (2.25 
 
m
 
g) and the wt HIV-1 en-
velope construct pMA243 (5 ng).
 
i
 
Cells were transfected with the negative control plasmid CMV-ENV
 
D
 
PvuII. 
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dimeric assembly of mutant and wt glycoproteins, with wt
homodimers being the sole functional combination.
 
Trans-dominant Negative Mutants Prevent the 
Intracellular Transport of the wt
Precursor Glycoprotein
 
The design of the dominant negative assay was based on
the assumption that a cleavage-defective mutant with
competence for assembly would prevent the wt glycopro-
tein from being transported to, and consequently cleaved
in, the Golgi apparatus. We used two complementary ap-
proaches to ascertain that this was indeed the inhibitory
step.
First, we performed in situ immunofluorescence analy-
ses to examine the intracellular localization of the wt
HTLV-1 glycoprotein expressed in the absence or pres-
 
ence of a cleavage-defective mutant (Fig. 3). When the wt
envelope construct was transfected alone, most of the pos-
itive cells were committed to the formation of syncytia,
and a granular staining scattered throughout the cyto-
plasm was detected (Fig. 3 b). In contrast, the staining was
confined to the perinuclear space in cells expressing any of
the cleavage-defective mutants (see the example of the
Arg379-Gly mutant in Fig. 3 c). We performed double-
label immunofluorescence experiments to identify the mu-
tant-retaining organelles. As shown in Fig. 4, the staining
for HTLV-1 glycoprotein mutant showed partial colocal-
ization both with that for translocating chain-associating
membrane protein (Fig. 4 a), an ER marker, and with that
for Rab1 (Fig. 4 b), an intermediate compartment and cis-
Golgi marker. The pattern of staining observed in cells co-
expressing the wt glycoprotein and a cleavage-defective
dominant negative mutant was similar to that in cells ex-
pressing the mutant alone (see Fig. 3 d). These results indi-
cate intracellular retention of wt glycoprotein in the pres-
ence of a trans-dominant negative mutant.
We next verified that the mutants that by themselves
were defective in precursor cleavage also impaired in trans
the cleavage of the wt envelope precursor (Fig. 5). Indeed,
when expressed in the absence of mutant, the wt precursor
gave rise to its mature products as appreciated by detec-
tion of the 20-kD band corresponding to the TM glycopro-
tein (Fig. 5, a, lane 2, and b, lane 2), whereas in the pres-
ence of any of the cleavage-defective dominant negative
mutants, the TM-gp20 was barely or not detected (Fig. 5,
a, lanes 3–10, and b, lanes 4–16).
Taken together, these data confirm our hypothesis that
the dominant negative effect exerted by cleavage-defec-
tive mutants results from their ability to prevent it from
being transported to and cleaved in the Golgi apparatus.
 
The Only Mutation that Impairs Precursor Assembly Is 
Located at the NH
 
2
 
 Terminus of the Glycoprotein
 
Among the 22 cleavage-defective HTLV-1 glycoprotein
mutants, the SU mutant Ser25-Arg represented a notable
exception: it spared 72% of the syncytium formation elic-
ited by the wt envelope (Table II). Immunofluorescence
microscopy showed that the Ser25-Arg mutant, like the
other cleavage-defective mutants, was defective in intra-
cellular transport (Fig. 3 e). Upon its coexpression with wt
glycoprotein, however, giant multinucleated cells with a
granular staining scattered throughout the cytoplasm were
detected (Fig. 3 f). The Ser25-Arg mutant thus failed to
abolish in trans the intracellular transport of the wt glyco-
protein, in sharp contrast with the other cleavage-defec-
tive HTLV-1 glycoprotein mutants. Furthermore, we con-
firmed that the cleavage of the wt glycoprotein was only
partially inhibited by coexpression of a threefold excess of
the Ser25-Arg mutant (Fig. 5 b, lane 3). We also verified
that the phenotype of the Ser25-Arg mutant was not due
to a greater instability of this glycoprotein compared with
the dominant negative mutants (data not shown). Thus,
assembly of the HTLV-1 envelope precursor is impaired
by a single amino acid substitution located at the NH
 
2
 
 ter-
minus of the glycoprotein (the serine at position 25 is the
fifth amino acid of the protein after removal of the signal
peptide; Lee et al., 1984).
Figure 1. Velocity gradient sedimentation of the envelope glyco-
proteins from lysates of cells coexpressing the wt HTLV-1 enve-
lope and a cleavage-defective mutant. COS-1 cells were trans-
fected with the following constructs: wt HTLV-1 envelope
(CMV-ENV-1), a 3:1 ratio of Arg379-Gly mutant plus wt HTLV-1
envelope, or a 3:1 ratio of Asp171-Tyr mutant plus wt HTLV-1
envelope. Cell lysates were loaded onto 5–35% sucrose gradients
and, after centrifugation, the distribution of the envelope precur-
sor glycoproteins across the gradients was determined by immu-
noprecipitation with sera from HTLV-1–infected individuals,
followed by SDS-PAGE and Western blotting with the anti–
HTLV-1 glycoprotein 4D4 mAb as the primary antibody. The
gradients were calibrated with BSA (66 kD), alcohol dehydroge-
nase (141 kD), and catalase (250 kD), with d indicating the ex-
pected position of the HTLV-1 envelope precursor dimer (size of
the monomer: 61 kD).The Journal of Cell Biology, Volume 145, 1999 62
The HTLV-1 and HTLV-2 Glycoproteins Have a 
Similar Determinant of Precursor Assembly
We asked whether HTLV-2, a human retrovirus phyloge-
netically related to HTLV-1, has comparable require-
Figure 2. Random dimerization in cells coexpressing the wt
HTLV-1 glycoprotein and an assembly-competent mutant. (a)
Theoretical curves expected from a random dimerization pro-
cess. In a cell that coexpresses the wt glycoprotein and an assem-
bly-competent mutant, three dimer combinations are possible:
homodimers of wt precursor subunits, homodimers of mutant
precursor subunits, and heterodimers consisting of both subunit
types. If dimerization is random and p is the fraction of wt mono-
mers, then the proportion of dimers consisting solely of wt sub-
units is given by p2 (dd). It follows that (1 2 p) represents the
fraction of mutant monomers; therefore, the proportion of ho-
modimers of mutant subunits is (1 2 p)2 (ss), and the propor-
tion of heterodimers is expressed by 2p(1 2 p) (sd). (b and c)
Syncytium formation as a function of the mutant:wt transfection
ratio. Cells were transfected with a constant amount of DNA
containing mutant:wt ratios of 3:1, 1:1, and 1:3. The theoretical
curve (broken line) gives the probability of wt homodimer for-
mation assuming that dimerization is random, as calculated in a.
Superimposed are the experimental data for the indices of syncy-
tium formation obtained at each mutant:wt ratio with (b) cleav-
age-defective mutants with single amino acid substitutions in the
TM or SU portions of the glycoprotein and (c) transport-compe-
tent mutants with COOH-terminal truncations of the glycopro-
tein. The plotted curves (full lines) were fitted to the experimen-
tal points using a polynomial method.
Figure 3. Immunofluorescence analysis of the intracellular distri-
bution of wt and mutated HTLV-1 glycoproteins. HeLa cells
were transfected with the following constructs: negative control
(CMV-ENVDPvuII) (a), wt HTLV-1 envelope (CMV-ENV-1)
(b), Arg379-Gly mutant (c), a 3:1 ratio of Arg379-Gly mutant
plus wt HTLV-1 envelope (d), Ser25-Arg mutant (e), or a 3:1 ra-
tio of Ser25-Arg mutant plus wt HTLV-1 envelope (f). Trans-
fected cells were fixed, permeabilized, and subjected to indirect
immunofluorescence staining with the anti–HTLV-1 glycopro-
tein 1C11 mAb as the primary antibody. Shown are equatorial
slices of representative fluorescent cells obtained by confocal mi-
croscopy. Bar, 10 mm.Rosenberg et al. Early Assembly of a Retroviral Envelope Glycoprotein 63
ments for envelope precursor assembly. We mutated the
serine residue at position 21 of the HTLV-2 envelope pro-
tein, equivalent to the serine at position 25 in HTLV-1
(Sodroski et al., 1984; Rosenberg et al., 1998). Like the
Ser25-Arg HTLV-1 mutant, the Ser21-Arg HTLV-2 mu-
tant by itself exhibited a cleavage-defective phenotype
(Table III). It also failed to abolish wt envelope-mediated
function when expressed in a threefold excess with the wt
HTLV-2 glycoprotein, sparing 85% of the syncytium-form-
ing activity (Table III). This shows that, in both HTLVs, the
substitution of one serine at the NH2 terminus of the glyco-
protein is sufficient to impair precursor assembly.
A COOH-Terminally Truncated, Soluble Form of the 
Glycoprotein Is Trans-dominant Negative
We generated mutants with truncations or deletions to
map the HTLV-1 glycoprotein domains involved in pre-
cursor assembly (Fig. 6). We verified that none of them
elicited syncytium formation when expressed alone (data
not shown), and we tested them for negative dominance.
A truncation mutant lacking the membrane-anchorage
and intracytoplasmic domains (ENV438-stop) abolished
the syncytium-forming activity of the wt HTLV-1 enve-
lope (Fig. 6). As for point mutants, the trans-dominant
negative effect was specific, because the truncated HTLV-1
glycoprotein mutant did not interfere with the syncytium
formation elicited by the wt HIV-1 envelope (data not
shown). It also followed the titration curve expected from
a random dimeric association of the two glycoproteins
(Fig. 2 c). The cleavage of the wt envelope precursor was
greatly impaired in cells coexpressing the ENV438-stop
mutant (Fig. 7, compare lane 2 1 with 1 1). Conversely,
secretion of the soluble products (SU of normal size and
truncated TM) of the ENV438-stop mutant was reduced in
the supernatant of these cells (data not shown). We con-
cluded that (a) the ectodomain of the HTLV-1 envelope
protein contains structural information that is sufficient
for precursor subunit association, and (b) the hetero-
dimers formed by the full-length wt glycoprotein and a
COOH-terminally truncated, soluble mutant are defective
in intracellular transport even though both subunits by
themselves are competent for this process (Pique et al.,
1993; Rosenberg et al., 1997).
The NH2 Terminus of the SU Portion Is Critical for 
Precursor Assembly
We further sought to determine which regions within the
HTLV-1 glycoprotein ectodomain are critical for intracel-
Figure 4. Partial colocalization of mutated HTLV-1 glycoprotein with both an ER marker and an intermediate compartment and cis-
Golgi marker. HeLa cells were transfected with the expression plasmid for Arg379-Gly mutant. Transfected cells were fixed, permeabi-
lized, and subjected to double immunofluorescence staining for detection of HTLV-1 glycoprotein (green) and marker (red), translo-
cating chain-associating membrane protein (TRAP) (a) or Rab1 (b). Shown in each row is one single optical plane recorded in both
green and red channels by confocal microscopy. Colocalization sites appeared as yellow pixels after merging the images (a3 and b3).
Bar, 10 mm.The Journal of Cell Biology, Volume 145, 1999 64
lular assembly. A major role could be attributed to the SU
portion, because a truncated mutant lacking all the TM se-
quences (SU313-stop) was sufficient to exert a strong
dominant negative effect (Fig. 6). The phenotype re-
mained unchanged after further truncations of the SU that
removed its COOH-terminal third (SU201-stop) or even
its COOH-terminal half (SU163-stop). Again, titration of
wt glycoprotein followed the theoretical curve expected
from a random dimerization process (Fig. 2 c). The cleav-
age of the wt envelope precursor was also greatly impaired
in cells coexpressing any of these three truncated proteins
(Fig. 7, lanes 31, 41, and 51). In contrast, an SU glyco-
protein deleted of its NH2-terminal half (SUD26-164) was
less effective in trans-inhibition of wt function, sparing
45% of the syncytium formation (Fig. 6). It was also less
effective in trans-inhibition of wt glycoprotein cleavage
(see Fig. 7, lane 61; the labeling of the mutated protein
Figure 5. Radioimmunoprecipitation of the envelope products
from lysates of cells coexpressing the wt HTLV-1 glycoprotein
and a cleavage-defective mutant. Transfected COS-1 cells were
metabolically labeled for 16 h, and the lectin-purified glycopro-
teins from the cell lysates were subjected to immunoprecipitation
with sera from HTLV-1–infected individuals. Positions of the
bands corresponding to the precursor (Prec) and TM glycopro-
teins are indicated on the left. (a) HTLV-1 glycoprotein mutants
with single amino acid substitutions in the TM portion. Cells
were transfected with the negative control plasmid (CMV-
ENVDPvuII) (lane 1) or with the wt HTLV-1 envelope expres-
sion plasmid CMV-ENV-1 plus a threefold excess of the follow-
ing constructs: (lane 2) negative control (CMV-ENVDPvuII),
(lane 3) Asp351-His, (lane 4) Leu368-Arg, (lane 5) Ala375-Asp,
(lane 6) Arg379-Gly, (lane 7) Asp383-Tyr, (lane 8) Glu398-Val,
(lane 9) Ser408-Phe, (lane 10) Leu419-Arg. (b) HTLV-1 glyco-
protein mutants with single amino acid substitutions in the SU
portion. Cells were transfected with the negative control plasmid
(CMV-ENVDPvuII) (lane 1), or with the wt HTLV-1 envelope
expression plasmid CMV-ENV-1 plus a threefold excess of the
following constructs: (lane 2) negative control (CMV-ENVD-
PvuII), (lane 3) Ser25-Arg, (lane 4) Leu52-Arg, (lane 5) Asp53-
Val, (lane 6) Ser58-Leu, (lane 7) Ser119-Leu, (lane 8) Tyr124-
Asp, (lane 9) Ser130-Ile, (lane 10) Ser162-Phe, (lane 11)
Asp171-Tyr, (lane 12) Ile173-Ser, (lane 13) Thr178-Ala, (lane 14)
His238-Leu, (lane 15) Ser292-Tyr, (lane 16) Leu295-Arg.
Table III. Effect of Cleavage-defective HTLV-2 SU Mutants on 
Syncytium Formation Induced by wt Envelope
HTLV-2 glycoprotein
mutant
Precursor cleavage
index (%) Syncytium formation index (%)
Mutant* Mutant* Mutant 1 wt HTLV-2 Env‡
Mock§ ,20 ,5 100
Ser21-Arg 33 11 85
Ser70-Phe ,20 ,57
*The indices for the HTLV-2 glycoprotein mutants relative to the wt HTLV-2 enve-
lope glycoprotein were calculated as described elsewhere (Rosenberg et al., 1998).
Data represent the means of two independent transfections.
‡Cells were cotransfected with the mutant constructs (2.25 mg) and the wt HTLV-2
envelope construct CMV-ENV-2 (0.75 mg). Data represent the means of two indepen-
dent transfections.
§Cells were transfected with the negative control plasmid CMV-ENVDPmaCI.
Figure 6. Effect of truncated and deleted HTLV-1 glycoprotein
mutants on syncytium formation induced by wt envelope. (left)
Schematic representations of wt, truncated, and deleted HTLV-1
glycoproteins. The hydrophobic stretches corresponding to the
signal peptide, fusion peptide, and membrane-anchorage domain
are depicted as hatched, dotted, and black boxes, repectively.
The intracytoplasmic (IC) domain is indicated. The position of
the cleavage site is shown with an arrow, those of the five N-gly-
cosylation sites with piled circles. The horizontal bar marks the
position of the leucine zipper-like motif within the TM
ectodomain. Internal deletions are shown with broken lines that
encompass the deleted regions. (Right) Effect of the truncated
and deleted mutants on syncytium formation induced by wt enve-
lope. Cells were cotransfected with the wt HTLV-1 envelope ex-
pression plasmid CMV-ENV-1 plus a threefold excess of the
truncated or deleted construct. The syncytium formation index
gives the percentage of fusion relative to that obtained after cell
cotransfection with the same amount of CMV-ENV-1 plus a
threefold excess of negative control (CMV-ENVDPvuII).Rosenberg et al. Early Assembly of a Retroviral Envelope Glycoprotein 65
was fainter than that of the other mutants because the de-
letion removed 10 of the 14 cysteine residues of the SU
glycoprotein). Therefore, the integrity of the NH2-termi-
nal domain of the SU was both necessary and sufficient for
full trans-dominant inhibition of the intracellular transport
and hence the function of the wt envelope. These findings
underscore the importance of the NH2-terminal domain in
the intracellular assembly of the glycoprotein.
The TM Portion Contributes to Precursor Assembly, 
but Not via the Leucine Zipper-like Domain
We reasoned that removal of the SU might unmask a po-
tential contribution of the TM portion in precursor assem-
bly. Indeed, a deletion mutant lacking most of the SU se-
quences (TM284-488) exerted a partial dominant negative
effect on wt function (coexpression in a 3:1 ratio resulted
in 40% syncytium-forming activity; Fig. 6). The effect
seemed mostly due to the COOH-terminal region of the
ectodomain, and not to the leucine zipper-like domain, be-
cause an NH2-terminally deleted protein lacking the leu-
cine zipper-like motif (TM384-488) still exerted a domi-
nant negative effect, whereas a TM protein deleted of the
COOH-terminal half of the ectodomain (TMD382-441)
was ineffective in trans-inhibition (Fig. 6). Thus, in addi-
tion to the contribution of the NH2-terminal domain of the
SU, a role in intracellular assembly could be attributed to
the COOH-terminal region of the TM ectodomain.
Physical Interaction between HTLV-1 Envelope 
Glycoproteins Having an Intact NH2 Terminus
Finally, we took advantage of truncation mutants to pro-
vide direct demonstration of the physical interaction be-
tween HTLV-1 envelope proteins having an intact NH2-
terminal domain. We used the 4D4 mAb, which is directed
to the COOH-terminal domain (amino acids 287–311) of
the HTLV-1 SU (Grange et al., 1998), to perform coimmu-
noprecipitation experiments (Fig. 8). The 4D4 mAb was
able to immunoprecipitate similar amounts of precursor
glycoproteins for the wt envelope, the Ser25-Arg mutant,
or a trans-dominant mutant, Arg379-Gly (Fig. 8, lanes 2–4),
but did not allow immunoprecipitation of the COOH-ter-
minally truncated envelope protein SU163-stop, which
does not contain the 4D4 epitope (Fig. 8, lane 11). How-
ever, the 4D4 mAb did coimmunoprecipitate the SU163-
stop protein together with the wt precursor glycoprotein in
cells coexpressing the two proteins (Fig. 8, lane 21).
Therefore, the dominant negative effect displayed by the
SU163-stop mutant could indeed be accounted for by the
physical association of the truncated protein with the wt
precursor glycoprotein in the coexpressing cell. A compa-
rable level of SU163-stop protein was also coimmunopre-
cipitated together with a trans-dominant glycoprotein,
Arg379-Gly, confirming that competence for assembly re-
sulted in coimmunoprecipitation (Fig. 8, lane 41). In con-
trast, a smaller amount of SU163-stop protein was brought
down from cells coexpressing the Ser25-Arg mutated gly-
coprotein (Fig. 8, lane 31). Similar results were obtained
Figure 7. Radioimmunoprecipitation of the envelope products
from lysates of cells coexpressing the wt HTLV-1 glycoprotein
and a truncation mutant. COS-1 cells were transfected with (1)
or without (2) the wt HTLV-1 envelope expression plasmid
CMV-ENV-1 plus a threefold excess of the following constructs:
negative control (CMV-ENVDPvuII) (1), CMV-ENV438-stop
(2), CMV-SU313-stop (3), CMV-SU201-stop (4), CMV-SU163-
stop (5), or CMV-SUD26-164 (6). Transfected cells were meta-
bolically labeled for 16 h, and the lectin-purified glycoproteins
from the cell lysates were subjected to immunoprecipitation with
sera from HTLV-1–infected individuals. Positions of molecular
weight markers (kilodaltons) are indicated on the right, positions
of the bands corresponding to the wt precursor (Prec) and TM
glycoproteins are indicated on the left.
Figure 8. Coimmunoprecipitation of HTLV-1 envelope glyco-
proteins when the NH2 terminus is intact. COS-1 cells were trans-
fected with (1) or without (2) the CMV-SU163-stop construct
plus the following constructs: negative control (CMV-ENVDPvuII)
(1), wt HTLV-1 envelope (CMV-ENV-1) (2), Ser25-Arg mutant
(3), or Arg379-Gly mutant (4). Transfected cells were metaboli-
cally labeled for 16 h, and the lectin-purified glycoproteins from
the cell lysates were subjected to immunoprecipitation with the
4D4 mAb directed to the COOH-terminal domain of the HTLV-1
SU. Positions of molecular weight markers (kilodaltons) are indi-
cated on the right, positions of the bands corresponding to the wt
or mutated precursor glycoproteins (Prec) and to the SU163-stop
glycoprotein are indicated on the left.The Journal of Cell Biology, Volume 145, 1999 66
when the SU201-stop mutant was tested instead of the
SU163-stop mutant (data not shown). These data provide
direct evidence that competence for assembly is impaired
by a single amino acid substitution in the NH2-terminal
domain of the glycoprotein.
Discussion
In this study, we designed a dominant negative assay to ex-
plore the basis for the transport defect of a series of mu-
tants of the HTLV-1 envelope, a glycoprotein which is
subject to a very tight quality control (Pique et al., 1990;
Delamarre et al., 1996). To our surprise, we found that,
provided the NH2 terminus was intact, all mutated forms
of the glycoprotein were capable of interfering in trans
with the wt. Incompetence for assembly thus cannot ex-
plain the incompetence for transport of a large series of re-
tained glycoproteins. It should be noted here that the mu-
tated HTLV-1 glycoproteins were not retained in the ER
alone, since we also observed partial colocalization with an
intermediate compartment and cis-Golgi marker. This is
reminiscent of the retention of a VSV G mutant, which has
been shown to involve cycling between the ER, intermedi-
ate compartment, and cis-Golgi (Hammond and Helenius,
1994).
It could be argued that, rather than resulting from an as-
sembly process, the trans-dominant interference exerted
by the HTLV-1 glycoprotein mutants might be due to a
nonspecific effect, such as the titration of a factor required
for the intracellular transport of membrane proteins. This
is very unlikely, however, because the HTLV-1 glycopro-
tein mutants had no effect on another retroviral glycopro-
tein, that of HIV-1. Moreover, coimmunoprecipitation ex-
periments provided direct demonstration of a physical
interaction between mutated glycoproteins exerting a
dominant negative effect and the wt HTLV-1 precursor
glycoprotein. Another caveat with the dominant negative
approach is that it could reflect the constitution of aggre-
gates rather than a true competence for oligomeric assem-
bly. Although this hypothesis seemed unlikely because of
the specificity of the trans inhibition, we addressed it di-
rectly by showing that the HTLV-1 glycoproteins from
cotransfected cells were not recovered as aggregates in su-
crose gradients. Moreover, for all mutants tested, the ex-
perimental titration curves for the dominant negative
effect followed the theoretical curve expected from a
dimeric assembly of the wt and mutated glycoproteins. We
infer from these observations that our dominant negative
assay reveals a specific dimeric assembly process taking
place between HTLV-1 envelope precursor glycoproteins
in the living cell.
For most membrane-anchored glycoproteins studied so
far, assembly in the ER is a late step which takes place af-
ter folding of the monomeric subunits (Doms et al., 1993).
We therefore expected that the majority of the transport-
defective HTLV-1 glycoprotein mutants would be non–
trans dominant, due either to a defect in the assembly step
per se or to a defect in a previous folding step necessary
for assembly. We found, on the contrary, that incompe-
tence for assembly was rarely responsible for the intracel-
lular retention of the mutated glycoproteins: 21 of the 22
glycoproteins incapable of transport were nevertheless ca-
pable of dimeric association with the wt precursor. These
data suggest that the assembly process unraveled here is
unlikely to occur as a late event in the acquisition of trans-
port competence. The apparent discrepancy between our
results and the previous studies reviewed in Doms et al.
(1993) can be resolved if one considers the methodology
employed in each case. In the kinetic analyses that sug-
gested that the essentially complete folding of monomers
is a prerequisite to oligomerization, velocity gradient sedi-
mentation was generally used as the assembly assay. Such
a technique can only pick those oligomers that are stable
enough to withstand detergent solubilization and centrifu-
gation (Einfeld and Hunter, 1988; Doms, 1990). Alterna-
tively, monoclonal antibodies have been employed, but
they too may detect only the mature, stable oligomer. An
assembly assay based on negative dominance is comple-
mentary to these biochemical methods, because it evalu-
ates the functional consequences of an interaction having
occurred between subunits within the cell, but which
would not necessarily have withstood the experimental
manipulations involved in protein isolation and may not
necessarily correspond to the ultimate oligomeric confor-
mation. With this in mind, our results suggest the occur-
rence of an early and transient assembly step of the glyco-
protein, preceding the appearance of the stable oligomer
having the quaternary structure required for transport.
Studies with HA (Copeland et al., 1986) have also sug-
gested that the intracellular assembly of membrane-
anchored proteins is in fact a multistep process, although
it is detected as a discrete event when studied by a single
method.
Even though the association of HTLV-1 envelope pre-
cursor subunits is presumed here to occur early in the mat-
uration process, it is a posttranslational event. Indeed, our
titration curves were consistent with a random association
of monomers having arisen from different polysomes. This
feature is shared by the HA glycoprotein (Boulay et al.,
1988), and is likely to be a general rule of the assembly of
membrane proteins, because their confinement to the ER
compartment and their oriented state in the plane of the
membrane facilitate spatial proximity between subunits
(Grasberger et al., 1986). By contrast, a posttranslational
mechanism is unlikely to be adopted by cytosolic oligo-
meric proteins (Gilmore et al., 1996).
Our work allowed us to map the structural domain in-
volved in the ER association of HTLV-1 envelope precur-
sor subunits to the NH2 terminus of the glycoprotein. This
conclusion was drawn from a number of concordant obser-
vations. First, of the 22 point mutants tested, the only one
that spared the intracellular transport of the wt precursor
had a single amino acid substitution at the NH2 terminus
of the glycoprotein. Second, this mutant did not allow
coimmunoprecipitation of an assembly-competent glyco-
protein, whereas a trans-dominant mutant did. Third, the
use of truncation and deletion mutants showed that the
NH2-terminal half of the SU was both necessary and suffi-
cient for full trans-dominant inhibition. Finally, we also
showed that HTLV-2 has a similar NH2-terminal determi-
nant of envelope precursor assembly. To our knowledge,
this study is the first to demonstrate the involvement of
the SU portion of retroviral glycoproteins in ER assemblyRosenberg et al. Early Assembly of a Retroviral Envelope Glycoprotein 67
of the precursor. This feature was probably obscured by
the fact that mature TM glycoproteins of retroviruses have
always been found as stable oligomers (Einfeld and Hunter,
1988, 1994; Pinter et al., 1989; Schawaller et al., 1989; Earl
et al., 1990; Rey et al., 1990; McGuire et al., 1992), whereas
mature SU glycoproteins have usually been detected as
monomers (Einfeld and Hunter, 1988, 1994; Earl et al.,
1990; Thomas et al., 1991). It should be noted, however,
that oligomers of mature SU glycoproteins were observed
in some studies (Owens and Compans, 1990; Weiss et al.,
1990; Tucker et al., 1991). Whatever the contribution of
SU to the oligomerization of the mature envelope glyco-
proteins may be, our study brings to light an SU require-
ment for the ER assembly of the HTLV-1 envelope pre-
cursor, and underscores that domains involved in the ER
assembly of precursor glycoproteins should not be directly
inferred from those defined for the mature oligomers.
The difficulties in interpreting structural data for pro-
teins that adopt different conformations in their lifetimes
are further exemplified by the study of the leucine zipper-
like motif present in the TM. Retroviral envelopes un-
dergo at least two successive oligomerization events: the
first is the assembly of the precursor glycoprotein in the
ER, while the second is the formation of the fusion-com-
petent oligomer triggered by receptor recognition at the
cell surface. Although it was first thought that the zipper
motif might fold into a coiled coil in the context of the pre-
cursor molecule, the leading hypothesis now is that it
drives only the second oligomerization event (Dubay et al.,
1992; Chen et al., 1993; Wild et al., 1994). Using an in vivo
experimental strategy, our study with the HTLV-1 enve-
lope glycoprotein further corroborates the idea that the
leucine zipper-like domain is not required for ER assem-
bly, since glycoproteins with deletions encompassing the
corresponding region were still capable of intracellular as-
sociation with the wt precursor.
Collectively, our data indicate that the NH2-terminal do-
main of the HTLV-1 envelope glycoprotein determines its
ER assembly at a step that is not the last one in the acqui-
sition of transport competence. The phenotype exhibited
by most of our HTLV-1 envelope mutants (i.e., transport
deficiency despite competence for oligomeric assembly)
was previously observed with mutants of HA0 (Gething
et al., 1986), VSV G (Doms et al., 1988), and the envelope
of the Moloney murine leukemia virus (Kamps et al.,
1991). Thus, oligomerization per se is not sufficient to
meet the quality control of the ER. The possibility of addi-
tional events in the maturation process was also suggested
by the observation of a significant time lag between the
ER dimerization of the HIV-1 envelope precursor and its
Golgi cleavage (Earl et al., 1991). What is the exact nature
of these postoligomerization events? It is possible that sig-
nificant folding of the subunits proceeds within the frame-
work of the oligomer. Consistent with this hypothesis, the
HIV-1 envelope precursor has been found to acquire reac-
tivity to stringent conformational antibodies only after its
oligomeric assembly (Otteken et al., 1996). Studies on the
reovirus cell attachment protein s1, a cytosolic protein,
have revealed a schema of protein maturation that may
also apply to membrane proteins in the ER. The matura-
tion of this protein involves an initial trimerization of the
NH2 terminus that, in turn, permits the trimerization of
the COOH terminus and completion of folding; the trans-
dominant negative effects exerted by COOH-terminally
truncated mutants led to the proposal that the folding of
the NH2-terminally assembled subunits is a cooperative
process requiring the integrity of all subunits (Leone et al.,
1992). A similar mechanism is likely to account for the
trans-dominant negative effects observed in our study of
the HTLV-1 glycoprotein. It is indeed noteworthy that not
only the heterodimers formed by the wt and any of the
transport-defective mutants but also those formed by the
wt and any of the COOH-terminally truncated, transport-
competent mutants were defective in transport. Together
with previous findings, our study thus emphasizes that the
condition imposed on membrane proteins by the cellular
quality control is not simply the acquisition of an oligo-
meric status as such, but rather the attainment of the cor-
rect quaternary structure. We propose that this process
involves the cooperative folding of “preassembled” sub-
units.
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